The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 4, 2006, Pages 1110-1116

  Malone, John M ^a   Saed, Ghassan M ^a   Diamond, Michael P ^a   Sokol, Robert J ^a   Munkarah, Adnan R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Inducible nitric oxide synthase; Ovarian cancer; Vascular endothelial growth factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER THERAPY; CELL ASSAY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY; OVARY CANCER; OVARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; UMBILICAL VEIN; UPREGULATION;

CELL LINE, TUMOR; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; OVARIAN NEOPLASMS; UMBILICAL VEINS;

EID: 33645851648     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.12.019     Document Type: Article

References (26)

1. Stepanian M., and Cohn D.E. Gynecologic malignancies in adolescents. Adolesc Med Clin 15 (2004) 549-568
2. Simpkins F., Zahurak M., Armstrong D., Grumbine F., and Bristow R. Ovarian malignancy in breast cancer patients with an adnexal mass. Obstet Gynecol 105 (2005) 507-513
3. Lecuru F., Metzger U., Levy E., Lefrere-Belda M.A., and Bensaid C. Ovarian cancer: diagnosis of early stages, referral of patients and management. Rev Prat 54 (2004) 1763-1769
4. Xu W., Liu L.Z., Loizidou M., Ahmed M., and Charles I.G. The role of nitric oxide in cancer. Cell Res 2 (2002) 311-320
5. Shang Z.J., and Li J.R. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. J Oral Pathol Med 34 (2005) 134-139
6. Mulrennan S.A., and Redington A.E. Nitric oxide synthase inhibition: therapeutic potential in asthma. Treat Respir Med 3 (2004) 79-88
7. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26 (2005) 33-65
8. Wang Y.Z., Cao Y.Q., Wu J.N., Chen M., and Cha X.Y. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA. World J Gastroenterol 11 (2005) 46-50
9. Peng J.P., Zheng S., Xiao Z.X., and Zhang S.Z. Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma. J Zhejiang Univ Sci 4 (2003) 221-227
10. Narayanan B.A., Narayanan N.K., Simi B., and Reddy B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res 63 (2003) 972-979
11. 2 on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Investig 9 (2002) 168-173
12. Munkarah A.R., Genhai Z., Morris R., Baker V.V., Deppe G., Diamond M.P., et al. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells. Gynecol Oncol 88 (2003) 429-433
13. Galijasevic S., Saed G.M., Diamond M.P., and Abu-Soud H.M. High dissociation rate constant of ferrous-dioxy complex linked to the catalase-like activity in lactoperoxidase. J Biol Chem 279 (2004) 39465-39470
14. Jaiswal M., LaRusso N.F., and Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281 (2001) G626-G634
15. Kong G., Kim E., Kim W., Lee Y., Lee J., Paik S., et al. Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer. Int J Gastrointest Cancer 29 (2001) 133-140
16. Ichinoe M., Mikami T., Shiraishi H., and Okayasu I. High microvascular density is correlated with high VEGF, iNOS and COX-2 expression in penetrating growth-type early gastric carcinomas. Histopathology 45 (2004) 612-618
17. Cianchi F., Cortesini C., Fantappie O., Messerini L., Schiavone N., Vannacci A., et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 162 (2003) 793-801
18. Davel L., D'Agostino A., Espanol A., Jasnis M.A., Lauria de Cidre L., de Lustig E.S., et al. Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration. J Biol Regul Homeost Agents 16 (2002) 181-189
19. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., and Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 72 (1995) 41-44
20. Reveneau S., Arnould L., Jolimoy G., Hilpert S., Lejeune P., Saint-Giorgio V., et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 79 (1999) 1215-1225
21. Raspollini M.R., Amunni G., Villanucci A., Boddi V., Baroni G., Taddei A., et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol Oncol 92 (2004) 806-812
22. Li W., Xu R.J., Jiang L.H., Shi J., Long X., and Fan B. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma. Med Oncol 22 (2005) 63-70
23. Jenkins D.C., Charles I.G., Baylis S.A., Lelchuk R., Radomski M.W., and Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70 (1994) 847-849
24. Cianchi F., Cortesini C., Fantappie O., Messerini L., Sardi I., Lasagna N., et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10 (2004) 2694-2704
25. Hellmuth M., Wetzler C., Nold M., Chang J.H., Frank S., Pfeilschifter J., et al. Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. Carcinogenesis 23 (2002) 1273-1279
26. Ghalayini I.F. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility. Int J Impot Res 16 (2004) 459-469